Display options
Cite
Ahmad YK, Tawfeek S, Sharaf-Eldin M, et al. Anti-Nuclear Cytoplasmic Antibody-Associated Vasculitis: A Probable Adverse Effect of Sofosbuvir Treatment in Chronic Hepatitis C Patients. Hosp Pharm. 2017;52(4):294-301doi: 10.1310/hpj5204-294.
Ahmad, Y. K., Tawfeek, S., Sharaf-Eldin, M., Elbatea, H. E., Kobtan, A., El-Kalla, F., Badawi, R., & Abd-Elsalam, S. (2017). Anti-Nuclear Cytoplasmic Antibody-Associated Vasculitis: A Probable Adverse Effect of Sofosbuvir Treatment in Chronic Hepatitis C Patients. Hospital pharmacy, 52(4), 294-301. https://doi.org/10.1310/hpj5204-294
Ahmad, Youssef K, et al. "Anti-Nuclear Cytoplasmic Antibody-Associated Vasculitis: A Probable Adverse Effect of Sofosbuvir Treatment in Chronic Hepatitis C Patients." Hospital pharmacy vol. 52,4 (2017): 294-301. doi: https://doi.org/10.1310/hpj5204-294
Ahmad YK, Tawfeek S, Sharaf-Eldin M, Elbatea HE, Kobtan A, El-Kalla F, Badawi R, Abd-Elsalam S. Anti-Nuclear Cytoplasmic Antibody-Associated Vasculitis: A Probable Adverse Effect of Sofosbuvir Treatment in Chronic Hepatitis C Patients. Hosp Pharm. 2017 Apr;52(4):294-301. doi: 10.1310/hpj5204-294. PMID: 28515509; PMCID: PMC5424834.
Copy Download .nbib Format: NLM
Share it on

Hosp Pharm. 2017 Apr;52(4):294-301. doi: 10.1310/hpj5204-294.

Anti-Nuclear Cytoplasmic Antibody-Associated Vasculitis: A Probable Adverse Effect of Sofosbuvir Treatment in Chronic Hepatitis C Patients.

Hospital pharmacy

Youssef K Ahmad, Salwa Tawfeek, Mohamed Sharaf-Eldin, Hassan E Elbatea, Abdelrahman Kobtan, Ferial El-Kalla, Rehab Badawi, Sherief Abd-Elsalam

PMID: 28515509 PMCID: PMC5424834 DOI: 10.1310/hpj5204-294

[No abstract available.]

Keywords: HCV; interferon; sofosbuvir; vasculitis

References

  1. Am J Kidney Dis. 2007 May;49(5):607-14 - PubMed
  2. N Engl J Med. 2013 May 16;368(20):1878-87 - PubMed
  3. Liver Int. 2010 Mar;30(3):342-55 - PubMed
  4. J Hepatol. 2011 Aug;55(2):245-64 - PubMed
  5. Br J Ophthalmol. 2001 Oct;85(10 ):1171-3 - PubMed
  6. J Hepatol. 2015 Jul;63(1):199-236 - PubMed
  7. Intern Med. 2001 Feb;40(2):105-9 - PubMed
  8. Lancet. 2001 Sep 22;358(9286):958-65 - PubMed
  9. Clin Immunol. 2005 Oct;117(1):87-93 - PubMed
  10. J Hepatol. 2014 Aug;61(2):373-95 - PubMed
  11. Curr Med Chem. 2006;13(27):3351-7 - PubMed
  12. Liver Int. 2011 Jul;31 Suppl 2:61-80 - PubMed
  13. Arthritis Rheum. 1999 Oct;42(10):2204-12 - PubMed
  14. Arch Dermatol. 1985 Feb;121(2):220-4 - PubMed
  15. Rheumatology (Oxford). 2008 Oct;47(10):1515-20 - PubMed
  16. Br J Surg. 1973 Aug;60(8):646-9 - PubMed
  17. Clin Pharmacol Ther. 1981 Aug;30(2):239-45 - PubMed
  18. J Clin Invest. 2002 Oct;110(7):955-63 - PubMed
  19. Hepatology. 1996 Aug;24(2):289-93 - PubMed
  20. N Engl J Med. 2011 Jun 23;364(25):2417-28 - PubMed
  21. Gut. 2006 Sep;55(9):1350-9 - PubMed
  22. Clin Microbiol Infect. 2011 Feb;17(2):107-15 - PubMed
  23. J Gen Virol. 2007 May;88(Pt 5):1526-31 - PubMed
  24. World J Nephrol. 2016 Nov 6;5(6):547-550 - PubMed
  25. Arthritis Rheum. 1994 Feb;37(2):181-6 - PubMed
  26. J Pharmacol Pharmacother. 2014 Oct;5(4):278-84 - PubMed
  27. J Pathol. 2000 Feb;190(3):349-59 - PubMed
  28. J Hepatol. 2015 Sep;63(3):581-5 - PubMed

Publication Types